Skopos Labs, Inc. Vera Therapeutics, Inc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,001 shares of VERA stock, worth $30,760. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,001
Previous 47
2029.79%
Holding current value
$30,760
Previous $1,000
2300.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
195Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$175 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$146 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$103 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$91 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$89.7 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $831M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...